Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease.
BACKGROUND: Chagas disease induced by Trypanosoma cruzi (T. cruzi) infection is a major cause of mortality and morbidity affecting the cardiovascular system for which presently available therapies are largely inadequate. Transforming Growth Factor beta (TGFß) has been involved in several regulatory...
Saved in:
Main Authors: | Fabiane L de Oliveira (Author), Tania C Araújo-Jorge (Author), Elen M de Souza (Author), Gabriel M de Oliveira (Author), Wim M Degrave (Author), Jean-Jacques Feige (Author), Sabine Bailly (Author), Mariana C Waghabi (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction: Oral Administration of GW788388, an Inhibitor of Transforming Growth Factor Beta Signaling, Prevents Heart Fibrosis in Chagas Disease.
by: PLOS Neglected Tropical Diseases Editors
Published: (2024) -
TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.
by: Roberto Rodrigues Ferreira, et al.
Published: (2019) -
PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer-Graphene Nanostars Reduces Liver Fibrosis and Inflammation
by: Alazne Moreno-Lanceta, et al.
Published: (2023) -
Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
by: Niu HS, et al.
Published: (2015) -
Expression of transforming growth factor beta in oral submucous fibrosis
by: Arpita Rai, et al.
Published: (2020)